This analysis looks at two prominent U.S. government and national-security technology providers: CACI International Inc. (CACI) and Leidos Holdings, Inc. (LDOS). Both generate most of their revenue from long-term federal contracts, which makes them relevant for investors interested in defense, intelligence, and government IT spending. Their recent performance and positioning have diverged, with CACI showing faster margin expansion and Leidos managing portfolio adjustments alongside a notable contract recompete. The discussion below reviews business models, recent results, growth factors, and risks to help assess the more compelling risk-adjusted opportunity.
CACI International (CACI) positions itself as a technology-focused national security firm serving the Department of Defense, intelligence community, and federal civilian agencies. Recent contract wins include counter-drone deployments under SkyValor, the Spectral naval electronic-warfare program, and classified space and intelligence work linked to the ARKA acquisition. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Fundamentals have improved. In the latest fiscal quarter, revenue reached roughly $2.48 billion, up about 8% year over year, with adjusted EPS rising in double digits and EBITDA margin expansion. Organic growth slowed to low single digits and total backlog stayed roughly flat, yet funded backlog and a quarterly book-to-bill ratio near 2.0x provide visibility. Management raised full-year revenue and adjusted EPS guidance, and sell-side coverage shows a consensus "Strong Buy" with recent upgrades and higher price targets.
Leidos Holdings (LDOS) operates as a diversified technology and engineering contractor across intelligence and digital, health, homeland security, and defense segments. Its work covers air-traffic management, energy infrastructure, managed health services, and defense products such as air-defense and sensing systems. Recent activity includes the ENTRUST Solutions acquisition and a joint venture combining its Security Enterprise Solutions unit with Analogic.
In the most recent quarter, Leidos posted revenue of about $4.63 billion, up roughly 4% year over year, though it missed top-line expectations with organic growth near 1%. Adjusted EPS rose about 19% and adjusted EBITDA margin held near 13.9%. Total backlog reached about $49.6 billion with a book-to-bill ratio of 1.2x, and free cash flow exceeded the original full-year target. Sentiment remains more cautious, however, following recent downgrades and uncertainty around the timing of a key Veterans Benefits Administration contract recompete.
The main differences center on focus and momentum. CACI (CACI) operates with greater concentration in technology-led classified and intelligence programs, which has supported steadier margin gains and a stronger book-to-bill ratio. Leidos (LDOS) offers broader diversification, including civil and health revenue that can stabilize results but also brings contract-specific risks such as the Veterans Benefits Administration recompete. Using Tickeron’s AI Pattern Search Engine confirmed the steadier trend consistency at CACI.
On growth, CACI guides to low-double-digit total revenue growth for fiscal 2027, partly from acquisitions, while Leidos manages lower organic growth amid portfolio shifts. Valuation and sentiment also differ: CACI holds a consensus "Strong Buy" with more positive analyst revisions, whereas Leidos carries a heavier "Hold" weighting and has seen several downgrades. Risks vary as well—CACI’s leverage from the ARKA deal remains elevated, while Leidos faces timing uncertainty on contract awards and thinner near-term organic growth.
Based on factors such as trend consistency, margin trajectory, analyst positioning, and relative momentum, Tickeron’s AI currently favors CACI (CACI) over Leidos (LDOS). CACI’s steadier margin expansion, higher book-to-bill ratio, and stronger consensus rating point to a more consistent positive setup, while Leidos’s mixed analyst sentiment and contract-recompete overhang add uncertainty. This view remains probabilistic, and positioning can shift with new earnings, awards, and budget developments.
In my own process, I frequently review Tickeron’s AI Trading Bots to understand how automated strategies are positioned across different market environments. This resource helps align automated approaches with specific objectives and risk levels when evaluating names in sectors like government contracting. It provides a practical way to monitor evolving dynamics without reviewing every strategy individually.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
On November 10, 2026, the Stochastic Oscillator for CACI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 43 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 73%.
CACI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CACI crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 70%.
Following a +5.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where CACI advanced for three days, in 232 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 126 of 242 cases where CACI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for CACI moved out of overbought territory on November 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In 29 of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CACI as a result. In 44 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.
The Moving Average Convergence Divergence Histogram (MACD) for CACI turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 22 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CACI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
CACI broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. CACI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.027) is normal, around the industry mean (2.898). P/E Ratio (25.171) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.224) among similar stocks. P/S Ratio (1.463) is also within normal values, averaging (139.965).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of professional services and information technology solutions
Industry InformationTechnologyServices